MedicalCV's Omnicarbon Heart Valve To Launch In August After 15-Year Wait

MedicalCV aims to capture 1-2% of the roughly $360 mil. worldwide mechanical heart valve market over the next year after gaining FDA approval of its Omnicarbon pyrolite ceramic-based heart valve on July 26.

More from Archive

More from Medtech Insight